Go to deals
Healthcare

Senectovia Medizinaltechnik AG has been acquired by a financial investor

In the context of succession in the ownership, a multi-family office has taken over Senectovia Medizinaltechnik AG. The owner of Senectovia has sold 100% of the shares and the two parties have agreed not to disclose the sale price.

Senectovia Medizinaltechnik AG is specialized in the distribution and maintenance of products for decubitus prophylaxis and therapy, patient mobility and obesity care. The product range includes medical mattresses and aids for patient positioning and mobilization. Thanks to the excellent service and high quality of its products, Senectovia has become the market leader in its core business in German-speaking Switzerland.

The buyer is a multi-family office that prefers to invest in mid-sized companies in healthcare and other industries. With this investor, Senectovia has gained a strong partner who will actively promote and further develop the company’s strategy and growth plans.

The previous owner, who has played a key role in shaping the company for over 20 years, will remain closely associated with Senectovia as a member of the Board of Directors, and will contribute his extensive industry experience to the management committee in order to provide the new investor with optimum support in implementing the initiated strategy.

Oaklins’ team in Switzerland supported the owner of Senectovia Medizinaltechnik AG during the entire sale process as exclusive M&A advisors. This included the preparation of the sale documents, the identification and approach of potential buyers, the supervision of the buy-side due diligence, as well as negotiations with several parties and support up to the signing and closing of the transaction.

Service
M&A sell-side
Parties
“With Oaklins, I had the optimal M&A advisor on my side, who accompanied me during a very challenging time for our company and implemented a succession process tailored to my needs. I would particularly like to highlight Oaklins' professionalism, industry knowledge and ability to ensure that always multiple options for action were kept open for me until closing. At all times in the process, Oaklins acted with foresight, anticipating potential stumbling blocks and preparing me in the best possible way for each step of the process.”

Michael Lienhart

Owner, Senectovia Medizinaltechnik AG

Talk to the deal team

 David  Zürrer

David Zürrer

Director
Basel, Switzerland
Oaklins Switzerland
Dr. Roberto  Tracia

Dr. Roberto Tracia

Partner
Bern, Switzerland
Oaklins Switzerland
 Roman  Thomet

Roman Thomet

Senior Associate
Zurich, Switzerland
Oaklins Switzerland

Related deals

SulAmérica and Rede D’Or São Luiz have announced a combination
Financial Services | Healthcare

SulAmérica and Rede D’Or São Luiz have announced a combination

SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.

Learn more
Agar Scientific has been acquired by Calibre Scientific
Private Equity | Healthcare

Agar Scientific has been acquired by Calibre Scientific

Agar Scientific Ltd. (Agar) has been sold to Molecular Dimensions Limited, a subsidiary of Calibre Scientific, Inc., a US-based life sciences company, owned by international private investment firm StoneCalibre.

Learn more
Cooper Consumer Health has sold Stardea to EA Pharma
Private Equity | Healthcare

Cooper Consumer Health has sold Stardea to EA Pharma

Cooper Consumer Health has sold Stardea to EA Pharma.

Learn more